Loading …

Allogenetics is redefining the multibillion transplant market with first-in-class, immune-evasive technology. We develop "Invisible Organs" to eliminate lifelong immunosuppression—treating the organ, not the patient. Join us in setting the new global standard for organ engineering and patient outcomes.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.